Re: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial

BÖLEK H., KUBİLAY TOLUNAY P.

ESMO Open, vol.10, no.9, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 10 Issue: 9
  • Publication Date: 2025
  • Doi Number: 10.1016/j.esmoop.2025.105765
  • Journal Name: ESMO Open
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Ankara University Affiliated: Yes